Friday, December 21, 2012

How many billions per year will the DSM-5 cost?

This was a really interesting article, because it gives a glimpse of the economic reality of the American medical system.  Among the parties involved - doctors, pharmaceutical companies, lawyers, and patients, there is but one incentive:  do more, prescribe more, treat more.  Whether patients are helped or hurt by these treatments seems to be of minimal concern, and certainly nobody is doing a cost-benefit analysis.  It is as if financial resources were infinite.

Read the comments at the bottom, too.

No comments: